Details for New Drug Application (NDA): 021481
✉ Email this page to a colleague
The generic ingredient in FUZEON is enfuvirtide. One supplier is listed for this compound. Additional details are available on the enfuvirtide profile page.
Summary for 021481
Tradename: | FUZEON |
Applicant: | Roche |
Ingredient: | enfuvirtide |
Patents: | 0 |
Suppliers and Packaging for NDA: 021481
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FUZEON | enfuvirtide | INJECTABLE;SUBCUTANEOUS | 021481 | NDA | Genentech, Inc. | 0004-0381 | 0004-0381-40 | 1 KIT in 1 CARTON (0004-0381-40) * 1 mL in 1 VIAL, SINGLE-USE * 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 90MG/VIAL | ||||
Approval Date: | Mar 13, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021481
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | FUZEON | enfuvirtide | INJECTABLE;SUBCUTANEOUS | 021481-001 | Mar 13, 2003 | 5,464,933 | ⤷ Subscribe |
Roche | FUZEON | enfuvirtide | INJECTABLE;SUBCUTANEOUS | 021481-001 | Mar 13, 2003 | 6,133,418 | ⤷ Subscribe |
Roche | FUZEON | enfuvirtide | INJECTABLE;SUBCUTANEOUS | 021481-001 | Mar 13, 2003 | 6,475,491 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription